Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited have received a request to issue of duplicate share certificate consequent to loss of share certifcate from the shareholder.
23-10-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2023.
10-10-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform that, the ESOP Allotment Committee of the Company at its meeting held on October 09, 2023, has approved the allotment of 2,74,150 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ("Bliss GVS ESOP-2019").
09-10-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct of Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ("the Company") will remain closed for Insiders, Designated Persons and its immediate relatives of the Compnay with effect from October 01, 2023 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023 generally made available to the public.
29-09-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We refer to our submission of disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 dated September 07, 2023, this is to inform you that a search was initiated by the Assistant Commissioner of State Tax Maharashtra, Mumbai ("Search Authority") at certain premises of the Company has been successfully concluded on September 09, 2023. Enclosed herewith the disclosure under Regulation 30 of SEBI Listing Regulations.
10-09-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015 ("SEBI Listing Regulation") read with Clause 19 of Schedule III of Part A of Para A of the SEBI Lisitng Regulations, we would like to inform you that the Assistant Commissioner of State Tax Maharashtra, Mumbai has initiated search on September 06, 2023, at certain premises of the Company. Enclosed herewith disclosure under Regulation 30.
07-09-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on August 29, 2023, has approved the allotment of 1,17,750 equity shares of face value of Re. 1/-each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019("Bliss GVS ESOP-2019").
29-08-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Report Of Violation Related To Code Of Conduct Under The SEBI (Prohibition Of Insider Trading) Regulations, 2015

 Please find enclosed herewith the reports related to the violation of the Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons of Bliss GVS Pharma Limited ("PIT Code") in the format prescribed by SEBI Circular SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020.
25-08-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper advertisement published regarding extract of the Unaudited Financial Results of the Company for the quarter ended June 30, 2023, ''The Economic Times & The Free Press Journal'' an English Daily and ''Maharashtra Times & Navshakti'' a Regional Daily, on August 03, 2023.
03-08-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, August 01, 2023

 We would like to inform you that the Board Meeting of the Company was held today i.e. Tuesday, August 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the Unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2023 along with the Limited Review Report and other business matters.
01-08-2023
Next Page
Close

Let's Open Free Demat Account